Akademisyen profili · PROFESÖR
YUSUF ÖZKAY
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Farmasotik Kimya
- ECZACILIK FAKÜLTESİ
- ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ
Scopus (SJR)
Q1
51
Q2
67
Q3
30
Q4
13
WoS (JCR)
Q1
31
Q2
65
Q3
38
Q4
26
TR Index
6
makale
Makaleler
- 2025 Multi-Target Quinoxaline Derivatives for Alzheimer’s Disease: Inhibitory Activities Against AChE and BACE-1 Enzymes
- 2025 Design, synthesis, and antiproliferative activity evaluation of novel cyclic secondary amine containing dithiocarbamate derivatives as potent EGFR inhibitors
- 2025 Design and Synthesis of Thiadiazole Derivatives as Dual EGFR/COX-2 Inhibitors with Anticancer and Anti-inflammatory Activities
- 2025 Synthesis of new piperazine‐oxadiazole derivatives and investigation of their anticancer activities
- 2025 Synthesis, biological evaluation and in silico studies of clopidogrel based new 1,2,4-triazole-3-thione derivatives as DNA methyltransferase inhibitors on prostate cancer cells
- 2025 Targeting Cancer with New Morpholine-Benzimidazole-Oxadiazole Derivatives: Synthesis, Biological Evaluation, and Computational Insights
- 2025 Synthesis and biological evaluation of novel naproxen–phenacetin triazole hybrids as promising anti-inflammatory agents with enhanced gastrointestinal tolerability
- 2025 Structure-based design, synthesis, and biological activity evaluation of chalcone-piperazine derivatives as dual AChE and MAO B inhibitors
- 2025 Synthesis, Characterization, and In vitro and In Silico Studies of New Triazole Derivatives as Aromatase Inhibitors
- 2025 Exploring SAR and Antifungal Activity of Pyrazole‐Thiazole‐Hydrazone Compounds Through Synthesis and Docking Studies
- 2025 Innovative Pyrazole–Thiazole–Oxadiazole Hybrid Compounds for Targeted EGFR/VEGFR2 Inhibition in Cancer Treatment
- 2025 Integrated (modular) education model in pharmacy: The Anadolu University case
- 2024 Design, synthesis, and investigation of biological activities of new triazole derivatives with antifungal effect
- 2024 Synthesis, characterization, biological evaluation and in silico studies of novel 1,3,4-thiadiazole derivatives as aromatase inhibitors
- 2024 Development and assessment of novel pyrazole–thiadiazol hybrid derivatives as VEGFR-2 inhibitors: design, synthesis, anticancer activity evaluation, molecular docking, and molecular dynamics simulation
- 2024 Novel Hydrazide‐Hydrazones Bearing a Benzimidazole Ring: Design, Synthesis, and Evaluation of Inhibitor Properties Against CA I and CA II Isozymes
- 2024 Synthesis, DFT Calculations, In Silico Studies, and Antimicrobial Evaluation of Benzimidazole-Thiadiazole Derivatives
- 2024 Metabolic engineering of Saccharomyces cerevisiae for enhanced taxadiene production
- 2024 New benzimidazole‐oxadiazole derivatives as potent VEGFR‐2 inhibitors: Synthesis, anticancer evaluation, and docking study
- 2024 In Vitro Enzyme Activity and Molecular Docking Studies of Pyrazoline Derivatives as Monoamine Oxidase Inhibitors